Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals, Isotope Labelled Compounds
No Data Available
Trichloroacetaldehyde-13C2 Hydrate is labelled Trichloroacetaldehyde Hydrate (T774055). Studies have shown that when used in pediatric sedation side effects such as hallucination, excessive sleep and seizures were observed. It is sometimes administered to patients being treated with cyclophosphamide and it is known to inhibit some aldehyde dehydrogenases.This compound is suitable for aldehyde dehydrogenase (ALDH).